Literature DB >> 19564373

Infection with Anaplasma phagocytophilum induces multilineage alterations in hematopoietic progenitor cells and peripheral blood cells.

J L Johns1, K C Macnamara, N J Walker, G M Winslow, D L Borjesson.   

Abstract

Infection with Anaplasma phagocytophilum, a gram-negative, lipopolysaccharide (LPS)-negative, obligate intracellular bacterium, results in multiple peripheral blood cytopenias. We hypothesized that infection with this organism would result in decreased bone marrow (BM) function and shifts in hematopoietic progenitor cells (HPCs) and lineage-committed cells in a well-established murine model of infection. HPCs and lineage-committed progenitors were enumerated in the BM and spleen during acute infection. BM cytokine production and BM CXCL12 expression were determined. Infection resulted in peripheral blood bicytopenia, marked decreases in the number of lineage-committed HPCs in the BM along with concurrent increases in the number of lineage-committed HPCs in the spleen, and a mixed, predominantly myelosuppressive BM cytokine environment. There was significant downregulation of CXCL12 in BM cells that may have been partially responsible for changes in HPC trafficking observed. Changes occurred in the absence of direct pathogen infection of BM cells. Hematopoietic lineage assessment demonstrated that there was loss of erythrocytes and B lymphocytes from the BM along with increased granulopoiesis. These changes were accompanied by splenomegaly due to lymphoid hyperplasia and increased hematopoiesis, most notably erythropoiesis. These changes largely mimic well-described inflammation and endotoxin-mediated effects on the BM and spleen; however, the numbers of peripheral blood neutrophils appear to be independently modulated as granulocytic hyperplasia does not result in neutrophilia. Our findings highlight a well-conserved series of events that we demonstrate can be instigated by an LPS-negative pathogen in the absence of an endotoxin-mediated acute proinflammatory response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19564373      PMCID: PMC2738004          DOI: 10.1128/IAI.00570-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  65 in total

1.  Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells.

Authors:  P Simmons; K Kaushansky; B Torok-Storb
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  Absence of tumor necrosis factor alpha, interleukin-6 (IL-6), and granulocyte-macrophage colony-stimulating factor expression but presence of IL-1beta, IL-8, and IL-10 expression in human monocytes exposed to viable or killed Ehrlichia chaffeensis.

Authors:  E H Lee; Y Rikihisa
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

3.  A primary production deficit in the thrombocytopenia of equine infectious anemia.

Authors:  T B Crawford; K J Wardrop; S J Tornquist; E Reilich; K M Meyers; T C McGuire
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Ehrlichiosis with pancytopenia and ARDS.

Authors:  P W Paparone; P Ljubich; G A Rosman; N T Nazha
Journal:  N J Med       Date:  1995-06

5.  Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.

Authors:  H E Broxmeyer; B Sherry; S Cooper; L Lu; R Maze; M P Beckmann; A Cerami; P Ralph
Journal:  J Immunol       Date:  1993-04-15       Impact factor: 5.422

6.  Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog.

Authors:  G Cacalano; J Lee; K Kikly; A M Ryan; S Pitts-Meek; B Hultgren; W I Wood; M W Moore
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

7.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

8.  IL-6-induced anaemia in rats: possible pathogenetic implications for anemia observed in chronic inflammations.

Authors:  M Jongen-Lavrencic; H R Peeters; H Rozemuller; W J Rombouts; A C Martens; G Vreugdenhil; M Pillay; P H Cox; M Bijser; G Brutel; F C Breedveld; A J Swaak
Journal:  Clin Exp Immunol       Date:  1996-02       Impact factor: 4.330

9.  Clinical and laboratory characteristics of human granulocytic ehrlichiosis.

Authors:  J S Bakken; J Krueth; C Wilson-Nordskog; R L Tilden; K Asanovich; J S Dumler
Journal:  JAMA       Date:  1996-01-17       Impact factor: 56.272

10.  Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue.

Authors:  H E Broxmeyer; S Cooper; G Cacalano; N L Hague; E Bailish; M W Moore
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  26 in total

1.  Species interactions in a parasite community drive infection risk in a wildlife population.

Authors:  Sandra Telfer; Xavier Lambin; Richard Birtles; Pablo Beldomenico; Sarah Burthe; Steve Paterson; Mike Begon
Journal:  Science       Date:  2010-10-08       Impact factor: 47.728

Review 2.  Hematopoiesis sculpted by pathogens: Toll-like receptors and inflammatory mediators directly activate stem cells.

Authors:  Julie R Boiko; Lisa Borghesi
Journal:  Cytokine       Date:  2011-11-12       Impact factor: 3.861

Review 3.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 4.  Inflammatory signals regulate hematopoietic stem cells.

Authors:  Megan T Baldridge; Katherine Y King; Margaret A Goodell
Journal:  Trends Immunol       Date:  2011-01-11       Impact factor: 16.687

5.  Neutrophils exposed to A. phagocytophilum under shear stress fail to fully activate, polarize, and transmigrate across inflamed endothelium.

Authors:  U Y Schaff; K A Trott; S Chase; K Tam; J L Johns; J A Carlyon; D C Genetos; N J Walker; S I Simon; D L Borjesson
Journal:  Am J Physiol Cell Physiol       Date:  2010-04-14       Impact factor: 4.249

Review 6.  Anaplasma phagocytophilum: deceptively simple or simply deceptive?

Authors:  Maiara S Severo; Kimberly D Stephens; Michail Kotsyfakis; Joao Hf Pedra
Journal:  Future Microbiol       Date:  2012-06       Impact factor: 3.165

7.  Myeloid Cells Restrict MCMV and Drive Stress-Induced Extramedullary Hematopoiesis through STAT1.

Authors:  Riem Gawish; Tanja Bulat; Mario Biaggio; Caroline Lassnig; Zsuzsanna Bago-Horvath; Sabine Macho-Maschler; Andrea Poelzl; Natalija Simonović; Michaela Prchal-Murphy; Rita Rom; Lena Amenitsch; Luca Ferrarese; Juliana Kornhoff; Therese Lederer; Jasmin Svinka; Robert Eferl; Markus Bosmann; Ulrich Kalinke; Dagmar Stoiber; Veronika Sexl; Astrid Krmpotić; Stipan Jonjić; Mathias Müller; Birgit Strobl
Journal:  Cell Rep       Date:  2019-02-26       Impact factor: 9.423

8.  Downregulation of CXCL12 signaling and altered hematopoietic stem and progenitor cell trafficking in a murine model of acute Anaplasma phagocytophilum infection.

Authors:  J L Johns; D L Borjesson
Journal:  Innate Immun       Date:  2011-09-29       Impact factor: 2.680

9.  Influence of Genetic Background on Hematologic and Histopathologic Alterations during Acute Granulocytic Anaplasmosis in 129/SvEv and C57BL/6J Mice Lacking Type I and Type II Interferon Signaling.

Authors:  Jennifer L Johns; Marielle L Discipulo; Amanda L Koehne; Kaitlin A Moorhead; Claude M Nagamine
Journal:  Comp Med       Date:  2017-03-01       Impact factor: 0.982

10.  Diminished hematopoietic activity associated with alterations in innate and adaptive immunity in a mouse model of human monocytic ehrlichiosis.

Authors:  Katherine C MacNamara; Rachael Racine; Madhumouli Chatterjee; Dori Borjesson; Gary M Winslow
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.